Fairchem Organics Ltd
Fairchem Organics Limited was established in 2019, wherein Fairchem Speciality Limited (FSL) transferred the businesses of Oleo chemicals and nutraceuticals as per the scheme of demerger. Fairchem Organics is engaged in manufacturing of specialty chemicals like dimer acid, linoleic acid, mixed tocopherol concentrate and sterols concentrate, which find application in various industries like nutraceuticals, paints, printing ink, detergents, adhesives, etc.[1]
- Market Cap ₹ 908 Cr.
- Current Price ₹ 697
- High / Low ₹ 1,308 / 693
- Stock P/E 150
- Book Value ₹ 226
- Dividend Yield 1.08 %
- ROCE 10.2 %
- ROE 7.51 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 30.3%
Cons
- The company has delivered a poor sales growth of 11.9% over past five years.
- Company has a low return on equity of 13.0% over last 3 years.
- Debtor days have increased from 42.4 to 58.4 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 306 | 397 | 643 | 648 | 621 | 538 | 477 | |
| 258 | 328 | 538 | 576 | 554 | 495 | 455 | |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 | 22 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% | 5% |
| 6 | 0 | 0 | 1 | 1 | 1 | 1 | |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 3 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 11 |
| Profit before tax | 42 | 56 | 91 | 59 | 55 | 30 | 9 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% | |
| 35 | 42 | 68 | 44 | 40 | 22 | 6 | |
| EPS in Rs | 32.62 | 52.15 | 33.41 | 31.10 | 16.87 | 4.64 | |
| Dividend Payout % | 0% | 11% | 25% | 22% | 24% | 44% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -6% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -31% |
| TTM: | -86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -24% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 13% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 | 281 |
| 67 | 57 | 62 | 50 | 7 | 63 | 54 | |
| 25 | 33 | 30 | 33 | 37 | 37 | 40 | |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 | 388 |
| 126 | 126 | 141 | 156 | 191 | 201 | 199 | |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 | 14 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 83 | 103 | 141 | 151 | 137 | 189 | 175 | |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 | 388 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 31 | 40 | 40 | 50 | 74 | -17 | |
| -24 | -23 | -34 | -14 | -18 | -26 | |
| -7 | -17 | -6 | -35 | -57 | 42 | |
| Net Cash Flow | 0 | 0 | -0 | 0 | 0 | 0 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 |
| ROCE % | 30% | 38% | 22% | 19% | 10% |
Documents
Announcements
-
Audio Link For Earning''s Con-Call
10h - Posted audio recording of Nov 11, 2025 earnings call on Q2 and H1 results for period ended Sep 30, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Newspaper publication for Unaudited Financial Results for quarter and half year ended September 30, 2025
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1d - Earnings Presentation for quarter and six months ended September 30, 2025
-
KMP Authorized Under Regulation 30(5) Of SEBI (LODR) Regulations, 2015
7 Nov - Unaudited Q2 results: revenue Rs11,152.27L; CFO retires Nov14; new CFO and CS appointed Nov15.
-
Appointment of Company Secretary and Compliance Officer
7 Nov - Unaudited Q2 results approved; revenue ₹11,152.27L; CFO/CS retire Nov 14, replacements effective Nov 15.
Annual reports
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Dec 2024Transcript PPT REC
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
Jun 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Dec 2023TranscriptNotesPPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
Business Segments
1) Oleo Chemicals (95% in FY24 vs 99% in FY22): [1] [2] The company’s key oleo chemical products include Dimer Acid, Linoleic Acid, Palmitic Acid, Monomer Acid, Isostearic Acid, etc. It is one of the only manufacturers of Linoleic Acid and Dimer Acid in India. [3]